The words don't seem to align with the numbers!!!!
The announcement released on the 31st of July infers that Recce has done all of the work/tests required to lodge their IND application with the FDA.
However the 4C estimates a further $774K to be spent on R&D in the next quarter.
This spend cannot relate to the clinical trials as these can only occur after the IND is granted.
I believe that the spend must therefore relate to pre-clinical tests. The amount forecast is the highest yet by Recce in any quarter so far.
So there must still be a long way to go to IND? Despite "BEING ON TRACK" !!!
hey big spender
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
-0.010(1.79%) |
Mkt cap ! $127.5M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 56.5¢ | 55.0¢ | $124.1K | 222.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 44090 | 55.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 1761 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |